Financial comparisons Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2025-01-17 pm EST 5-day change 1st Jan Change
12.39 USD -1.04% Intraday chart for Myriad Genetics, Inc. -16.45% -9.63%
Main competitors
Add to a list
Revenues Net margin Operating Margin ROE ROA Leverage (Debt/EBITDA)
753,200,000.00 -34.96%-3.39%-2.71x-1.93x16.25x
3,782,031,491.20 +9.74%+11.95%9.73x6.85x0.2x
536,479,095.96 +42.08%+48.23%23.72x20.31x-0.54x
1,296,429,000.00 +25.20%+42.08% - - -
1,181,434,599.16 +13.85%+24.65%10.46x - 2.07x
563,948,000.00 -85.02%-100.14%-438.13x-28.23x0.07x
606,650,702.40 +27.40%+30.73%14.92x11.05x-0.43x
314,601,749.30 -109.65%-102.19%3.05x2.43x1.08x
618,727,000.00 -41.23%-42.88%-32.98x-25.59x1.69x
137,403,582.30 +35.79% - - - -
377,467,837.10 +17.64%+19.86%10.86x8.08x -
217,030,038.64 +6.70% - - - -
142,469,590.03 +24.56%+28.28%15.74x14.58x-1.5x
395,332,292.59 +10.80%+11.44%4.94x - -
237,767,980.45 +30.07%+34.10%14.93x - -
450,358,204.55 -71.33%-37.83%-15.56x-13.27x1.3x
156,414,258.22 +28.68%+30.12%20.42x14.03x -
104,799,090.32 -10.36%-21.32%-3.73x - 7.77x
Average 659,585,806.23 -4.45% -1.64% -24.29x 0.76x 2.54x
Weighted average by Cap. 1,430,619,292.76 +1.06% +5.03% -34.67x 3.10x 0.95x
Diagnostic & Testing Substances